Press release
Biosimilars Market Size 2020 Analysis by Segments, Drivers, Regions, Top Key Players And Forecast 2023
Biosimilars Market
The global biosimilars market was worth $7.79 billion in 2019. It is expected to grow at a compound annual growth rate (CAGR) of 31.70% and reach $23.63 billion by 2023.
Place a DIRECT PURCHASE ORDER of The Entire 140+ Pages Report @
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2807
The biosimilars market consists of sales of biosimilars and related services that are used to treat chronic diseases such as diabetes, arthritis, and cancer. Biosimilars are pharmaceuticals that are manufactured using cell lines and offers no clinical difference as compared to biologics. Biosimilars are made once the patent of biologics is expired.
The rising prevalence of chronic diseases such as arthritis, asthma, and cancer is expected to be a major driver of the biosimilars market. Long working hours, limited physical activity, unhealthy eating and drinking habits contribute to the prevalence of chronic diseases and biosimilars are increasingly used to treat these chronic diseases. Biosimilars activate the immune system response against cancer cells thus helping the immune system to eliminate the cancer cells from the body. According to a United Nations article, by 2030 the proportion of global deaths due to chronic diseases is expected to increase to 70% of total deaths. The global burden of chronic disease is expected to reach about 60%. Therefore, the rise in the prevalence of chronic diseases is projected to propel the demand for biosimilars, thus driving the biosimilars market.
Biosimilars Market Segmentation: -
By Product
Recombinant Non-glycosylated Proteins
Recombinant Glycosylated Proteins
By Types
Human Growth Hormone
Erythropoietin
Monoclonal antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Others
By Application
Oncology
Chronic and Autoimmune Diseases
Growth Hormone Deficiency
Infectious Diseases
Others
Browse Complete Report @
https://www.thebusinessresearchcompany.com/report/biosimilars-market-global-report
Few Points From Table Of Content
1. Executive Summary
2. Biosimilars Market Characteristics
3. Biosimilars Market Size And Growth
4. Biosimilars Market Segmentation
5. Biosimilars Market Regional And Country Analysis
.
.
.
25. Biosimilars Market Competitive Landscape And Company Profiles
26. Key Mergers And Acquisitions In The Biosimilars Market
27. Biosimilars Market Trends And Strategies
28. Biosimilars Market Future Outlook and Potential Analysis
29. Appendix
The report covers the trends and market dynamics of the Biosimilars Market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.
Request for a Sample Copy of This Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=2807&type=smp
Some of the key players involved in the Biosimilars Market are Pfizer, Amgen, Biocon, Celltrion, Dr. Reddy`s Laboratories, Boehringer Ingelheim, Elli Lilly and Company, Mylan N.V., Sanofi, STADA Arzneimittel, Sandoz International, Samsung Bioepis, Teva Pharmaceuticals, Apotex, AMEGA Biotech S.A., Bioton S.A.
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on Blog: http://blog.tbrc.info/
About US:
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets after WHO declared COVID-19 as a pandemic.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Biosimilars Market Size 2020 Analysis by Segments, Drivers, Regions, Top Key Players And Forecast 2023 here
News-ID: 2189278 • Views: …
More Releases from The Business research company
AR And VR Smart Glasses Market Research, Size, Share, Growth, Major Companies An …
The ar and vr smart glasses market size has grown rapidly in recent years. It will grow from $15.93 billion in 2023 to $18.58 billion in 2024 at a compound annual growth rate (CAGR) of 16.6%. The growth in the historic period can be attributed to gaming and entertainment applications, enterprise adoption, increased mobile connectivity, r&d investments, healthcare and medical applications.
The ar and vr smart glasses market size is…
Animal Derivatives Market Trend, Business Opportunities, Growth Prospect And For …
The animal derivatives market size has grown strongly in recent years. It will grow from $11.85 billion in 2023 to $12.66 billion in 2024 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to traditional use in food industry, growing global population, rising disposable income, cultural and dietary preferences, nutritional content and protein demand.
The animal derivatives market size is expected…
Aircraft Oxygen Systems Market Size, Share, Trends, Growth, Key Players, Strateg …
The aircraft oxygen systems market size has grown strongly in recent years. It will grow from $5.33 billion in 2023 to $5.67 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to aviation safety regulations, industry collaboration and research, emergency preparedness focus, passenger safety emphasis, global air travel expansion..
The aircraft oxygen systems market size is expected…
AI In Sports Market Growth, Key Players, Recent Developments And Forecast 2033
The ai in sports market size has grown exponentially in recent years. It will grow from $1.85 billion in 2023 to $2.43 billion in 2024 at a compound annual growth rate (CAGR) of 31.2%. The growth in the historic period can be attributed to performance optimization demands, fan engagement enhancement, injury prevention and management, strategic decision-making, market competitiveness.
The ai in sports market size is expected to see exponential growth…
More Releases for Biosimilars
Global Biosimilars Market 2021-2028 | Price Advantage of Biosimilars Over Biolog …
The global Biosimilars market focuses on encompassing major statistical evidence for the Biosimilars industry as it offers our readers a value addition on guiding them in encountering the obstacles surrounding the market. A comprehensive addition of several factors such as global distribution, manufacturers, market size, and market factors that affect the global contributions are reported in the study. In addition, the Biosimilars study also shifts its attention with an in-depth…
Growth of the Biosimilars Market Is Mainly Driven by Increasing Number of Approv …
A biosimilar is a biologic medical product that is similar to another already approved biological medicine, in terms of quality, safety, and efficacy. Biosimilars are a class of therapeutic drugs that provide additional treatment options and help reduce healthcare costs. Thus, there is an increasing demand for biosimilar drugs due to increasing prevalence of autoimmune diseases, key factor driving the growth of the biosimilars market. According to the National Stem…
Global Oncology Biosimilars Market | Global Oncology Biosimilars Industry | Onco …
The oncology biosimilars market involves of sales of medicine and drug interrelated products for cancer treatment. Biosimilars are pharmaceuticals which are produced using cell lines and are fashionable to the manufacturer. The manufacturing of such cell line processes is a multipart and time-consuming procedure.
According to the report analysis, ‘Oncology Biosimilars Market Global Report 2020-30’ states that the worldwide oncology biosimilars market was worth USD 2990.34 million in 2019. It is…
Global Biosimilars Market | Global Biosimilars Industry | Global Biosimilars Mar …
The biosimilars market involves of sales of biosimilars and associated services that are cast-off to treat chronic sicknesses such as diabetes, arthritis, and cancer. The Biosimilars are pharmaceuticals that are produced using cell lines and offers no clinical difference as linked to biologics. The Biosimilars are made once the patent of biologics is deceased.
According to the report analysis, ‘Biosimilars Market Global Report 2020-30’ states that the worldwide biosimilars market was…
Global Oral Biologics and Biosimilars Market | Global Oral Biologics and Biosimi …
The oral biologics and biosimilar market contain of sales of oral biologics and biosimilar products and associated services utilized to treat chronic syndromes such as diabetes, arthritis, cancer. Biologics are drugs completed from living cells using exceedingly complex technology while biosimilars are generated to function similarly to biologics but are not matching to biologics. Biosimilars offer energetic properties as any licensed biologic drug. The oral biologics and biosimilar market encompass…
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Diabetes is a group of metabolic disease characterized by high blood sugar level due to inadequate secretion of insulin. Common symptoms of diabetes include increased hunger, tiredness, weight loss, and excessive thirst and urination. The prevalence of diabetes is increasing, in turn, boosting demand for insulin biosimilar. For instance, according the World Health Organization (WHO) report in 2014, globally around 422 million adults were living with diabetes and 1.5 million…
